1. The Reformulation of OxyContin and Availability of Substance Use Treatment Facilities in the United States. (2025). DiNardi, Michael.
   In: MPRA Paper.
   RePEc:pra:mprapa:124502.

   Full description at Econpapers || Download paper

2. Spillovers of the Heroin Epidemic on Grandparent Caregiving. (2024). Laurito, Agustina.
   In: Population Research and Policy Review.
   RePEc:kap:poprpr:v:43:y:2024:i:2:d:10.1007_s11113-024-09870-x.

   Full description at Econpapers || Download paper

3. The devastating dance between opioid and housing crises: Evidence from OxyContin reformulation. (2024). Fu, Wei ; You, Shijun ; Bradford, Ashley C.
   In: Journal of Health Economics.
   RePEc:eee:jhecon:v:98:y:2024:i:c:s0167629624000754.

   Full description at Econpapers || Download paper

4. Choices and Implications when Measuring the Local Supply of Prescription Opioids. (2022). Cho, David ; Montes, Joshua ; Mezza, Alvaro.
   In: Finance and Economics Discussion Series.
   RePEc:fip:fedgfe:2022-78.

   Full description at Econpapers || Download paper

5. Local access to mental healthcare and crime. (2022). Deza, Monica ; Solomon, Keisha ; MacLean, Johanna Catherine.
   In: Journal of Urban Economics.
   RePEc:eee:juecon:v:129:y:2022:i:c:s0094119021000929.

   Full description at Econpapers || Download paper

6. Labor Market Effects of the Oxycodone-Heroin Epidemic. (2021). Garcia, Daniel ; Cho, David ; Weingarden, Alison E.
   In: Finance and Economics Discussion Series.
   RePEc:fip:fedgfe:2021-25.

   Full description at Econpapers || Download paper

7. Is the Rise in Illicit Opioids Affecting Labor Supply and Disability Claiming Rates?. (2020). Powell, David ; Park, Sujeong.
   In: NBER Working Papers.
   RePEc:nbr:nberwo:27804.

   Full description at Econpapers || Download paper

8. Local Access to Mental Healthcare and Crime. (2020). Maclean, Johanna ; Deza, Monica ; Solomon, Keisha T.
   In: NBER Working Papers.
   RePEc:nbr:nberwo:27619.

   Full description at Econpapers || Download paper

9. The Evolving Consequences of OxyContin Reformulation on Drug Overdoses. (2020). Powell, David ; Pacula, Rosalie.
   In: NBER Working Papers.
   RePEc:nbr:nberwo:26988.

   Full description at Econpapers || Download paper

1. Alpert, A., Powell, D., & Pacula, R. (2018). Supply‐side drug policy in the presence of substitutes: Evidence from the introduction of abuse‐deterrent opioids. American Economic Journal: Economic Policy, 10(4).

2. Andre, F. E. (1990). Overview of a 5‐year clinical experience with a yeast‐derived hepatitis b vaccine. Vaccine, 8, S74–S78.
   Paper not yet in RePEc: Add citation now
   

3. Baker, S. R., & Fradkin, A. (2017). The impact of unemployment insurance on job search: Evidence from google search data. Review of Economics and Statistics, 99(5), 756–768.

4. Beheshti, D. (2017). Cross‐state spillovers from medical marijuana laws: University of Texas at Austin Working Paper.
   Paper not yet in RePEc: Add citation now
   
5. Brady, J. E., Wunsch, H., DiMaggio, C., Lang, B. H., Giglio, J., & Li, G. (2014). Prescription drug monitoring and dispensing of prescription opioids. Public Health Reports, 129(2), 139–147.
   Paper not yet in RePEc: Add citation now
   

6. Buchmueller, T. C, & Carey, C. (2018). The effect of prescription drug monitoring programs on opioid utilization in medicare. American Economic Journal: Economic Policy, 10(1), 77–112.

7. Butler, S. F., Cassidy, T. A., Chilcoat, H., Black, R. A., Landau, C., Budman, S. H., & Coplan, P. M. (2013). Abuse rates and routes of administration of reformulated extended‐release oxycodone: Initial findings from a sentinel surveillance sample of individuals assessed for substance abuse treatment. The Journal of Pain, 14(4), 351–358.
   Paper not yet in RePEc: Add citation now
   
8. Carise, D., Dugosh, K. L., McLellan, A. T., Camilleri, A., Woody, G. E., & Lynch, K. G. (2007). Prescription oxycontin abuse among patients entering addiction treatment. American Journal of Psychiatry, 164(11), 1750–1756.
   Paper not yet in RePEc: Add citation now
   

9. Case, A., & Deaton, A. (2015). Rising morbidity and mortality in midlife among White non‐Hispanic Americans in the 21st century. Proceedings of the National Academy of Sciences, 112(49), 15078–15083.

10. Case, A., & Deaton, A. (2017). Mortality and morbidity in the 21st century. Brookings papers on economic activity, 2017, 397.

11. Chu, Y.‐W. L. (2015). Do medical marijuana laws increase hard‐drug use? The Journal of Law and Economics, 58(2), 481–517.

12. Cicero, T. J., & Ellis, M. S (2015). Abuse‐deterrent formulations and the prescription opioid abuse epidemic in the United States: Lessons learned from OxyContin. JAMA psychiatry, 72(5), 424–430.
    Paper not yet in RePEc: Add citation now
    
13. Cicero, T. J., Ellis, M. S., & Surratt, H. L. (2012). Effect of abuse‐deterrent formulation of OxyContin. New England Journal of Medicine, 367(2), 187–189.
    Paper not yet in RePEc: Add citation now
    

14. Colman, S., & Joyce, T. (2011). Regulating abortion: Impact on patients and providers in texas. Journal of Policy Analysis and Management, 30(4), 775–797.

15. Conti, G., & Sobiesk, E. (2007). An honest man has nothing to fear: User perceptions on web‐based information disclosure. In Proceedings of the 3rd symposium on usable privacy and security, ACM, pp. 112–121.
    Paper not yet in RePEc: Add citation now
    

16. Cunningham, S., Lindo, J. M., Myers, C., & Schlosser, A. (2017). How far is too far? New evidence on abortion clinic closures, access, and abortions: National Bureau of Economic Research.

17. Dave, D. M., Grecu, A. M., & Saffer, H. (2017). Mandatory access prescription drug monitoring programs and prescription drug abuse: National Bureau of Economic Research.

18. Degenhardt, L., Peacock, A., Colledge, S., Leung, J., Grebely, J., Vickerman, P., … Lynskey, M.(2017). Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: A multistage systematic review. The Lancet Global Health, 5(12), e1192–e1207.
    Paper not yet in RePEc: Add citation now
    

19. Doleac, J. L., & Mukherjee, A. (2018). The moral hazard of lifesaving innovations: Naloxone access, opioid abuse, and crime.SSRN Working Papers.

20. Evans, W. N., Lieber, E., & Power, P. (2018). How the reformulation of OxyContin ignited the heroin epidemic: National Bureau of Economic Research.

21. Fischer, S., Royer, H., & White, C. (2017). The impacts of reduced access to abortion and family planning services on abortion, births, and contraceptive purchases.

22. Harris, A. M. (2016). Increases in acute hepatitis B virus infections—Kentucky, Tennessee, and West Virginia. MMWR. Morbidity and mortality weekly report, 65, 2006–2013.
    Paper not yet in RePEc: Add citation now
    

23. Hollingsworth, A., Ruhm, C. J., & Simon, K. (2017). Macroeconomic conditions and opioid abuse. Journal of Health Economics, 56, 222–233.

24. Iyengar, S., Tay‐Teo, K., Vogler, S., Beyer, P., Wiktor, S., de Joncheere, K., & Hill, S. (2016). Prices, costs, and affordability of new medicines for hepatitis c in 30 countries: An economic analysis. PLoS medicine, 13(5), e1002032.

25. Kim, W. (2009). Epidemiology of hepatitis b in the united states. Hepatology, 49(S5).
    Paper not yet in RePEc: Add citation now
    

26. Klevens, R. M., Liu, S., Roberts, H., Jiles, R. B., & Holmberg, S. D. (2014). Estimating acute viral hepatitis infections from nationally reported cases. American journal of public health, 104(3), 482–487.

27. Knight, B. (2013). State gun policy and cross‐state externalities: Evidence from crime gun tracing. American Economic Journal: Economic Policy, American Economic Association, 5(4), 200–229.

28. Kolodny, A., Courtwright, D. T., Hwang, C. S., Kreiner, P., Eadie, J. L., Clark, T. W., & Alexander, G. C. (2015). The prescription opioid and heroin crisis: A public health approach to an epidemic of addiction. Annual review of public health, 36, 559–574.
    Paper not yet in RePEc: Add citation now
    
29. Li, G., Brady, J. E., Lang, B. H., Giglio, J., Wunsch, H., & DiMaggio, C. (2014). Prescription drug monitoring and drug overdose mortality. Injury epidemiology, 1(1), 9.
    Paper not yet in RePEc: Add citation now
    

30. Lovenheim, M. F. (2008). How far to the border?: The extent and impact of cross‐border casual cigarette smuggling. National Tax Journal, 61(1).

31. Ly, K. N., Xing, J., Klevens, R. M., Jiles, R. B., Ward, J. W., & Holmberg, S. D. (2012). The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007. Annals of internal medicine, 156(4), 271–278.
    Paper not yet in RePEc: Add citation now
    
32. McCabe, S. E., Cranford, J. A., Boyd, C. J., & Teter, C. J. (2007). Motives, diversion and routes of administration associated with nonmedical use of prescription opioids. Addictive behaviors, 32(3), 562–575.
    Paper not yet in RePEc: Add citation now
    
33. Mitchell, T., Armstrong, G. L., Hu, D. J., Wasley, A., & Painter, J. A. (2011). The increasing burden of imported chronic hepatitis B–United States, 1974‐2008. PloS one, 6(12), e27717.
    Paper not yet in RePEc: Add citation now
    
34. National notifiable diseases surveillance system (2015). Viral Hepatitis Surveillance‐United States, 2015. Centers for Disease Control and Prevention.
    Paper not yet in RePEc: Add citation now
    
35. Obama, B. (2016). Remarks by the president in panel discussion at the national prescription drug abuse and heroin summit. https://www.whitehouse.gov/the-press-office/2016/03/29/remarks‐presiden t‐panel‐discussion‐national‐prescription‐drug‐abuse‐and, Accessed: 2016 07 21.
    Paper not yet in RePEc: Add citation now
    
36. Opiate Addiction and Treatment Resource (2013). Old OxyContin (OC) vs new OxyContin (OP). http://www.opiateaddictionresource.com/media/images/oc_vs_op (Accessed: 2018‐05‐22).
    Paper not yet in RePEc: Add citation now
    
37. Paulozzi, L. J., Kilbourne, E. M., & Desai, H. A. (2011). Prescription drug monitoring programs and death rates from drug overdose. Pain medicine, 12(5), 747–754.
    Paper not yet in RePEc: Add citation now
    
38. Powell, D., Alpert, A., & Pacula, R. L. (2019). A transitioning epidemic: How the opioid crisis is driving the rise in hepatitis C. Health Affairs, 38(2), 287–294.
    Paper not yet in RePEc: Add citation now
    

39. Powell, D., Pacula, R. L., & Taylor, E. (2015). How increasing medical access to opioids contributes to the opioid epidemic: Evidence from medicare part d: National Bureau of Economic Research.

40. Powell, D., Pacula, R., & Jacobson, M. (2018). Do medical marijuana laws reduce addictions and deaths related to pain killers? Journal of Health Economics, 58, 29–42.

41. Roberts, H., Kruszon‐Moran, D., Ly, K. N., Hughes, E., Iqbal, K., Jiles, R. B., & Holmberg, ScottD(2016). Prevalence of chronic hepatitis b virus (hbv) infection in us households: National health and nutrition examination survey (nhanes), 1988‐2012. Hepatology, 63(2), 388–397.
    Paper not yet in RePEc: Add citation now
    
42. Rosenthal, E. S, & Graham, C. S (2016). Price and affordability of direct‐acting antiviral regimens for hepatitis c virus in the United States. Infectious agents and cancer, 11(1), 24.
    Paper not yet in RePEc: Add citation now
    

43. Schnell, M., & Currie, J. (2017). Addressing the opioid epidemic: Is there a role for physician education? American Journal of Health Economics, 1–37.

44. Stepanova, M., & Younossi, Z. M (2017). Economic burden of hepatitis c infection. Clinics in liver disease, 21(3), 579–594.
    Paper not yet in RePEc: Add citation now
    
45. Stephens‐Davidowitz, S. (2014). The cost of racial animus on a black candidate: Evidence using google search data. Journal of Public Economics, 118, 26–40.
    Paper not yet in RePEc: Add citation now
    
46. Tohme, R. A., & Holmberg, S. D. (2010). Is sexual contact a major mode of hepatitis c virus transmission? Hepatology, 52(4), 1497–1505.
    Paper not yet in RePEc: Add citation now
    
47. Tourangeau, R., & Yan, T. (2007). Sensitive questions in surveys. Psychological bulletin, 133(5), 859.
    Paper not yet in RePEc: Add citation now
    
48. Trump, D. J. (2018). Together, we will face this challenge as a national family with conviction, with unity, and with a commitment to love and support our neighbors in times of dire need. working together, we will defeat this #opioidepidemic. https://twitter.com/realdonaldtrump/status/969324283036971009?lang=en [Tweet] (Accessed: 2018‐05‐22).
    Paper not yet in RePEc: Add citation now
    

49. Valdiserri, R., Khalsa, J., Dan, C., Holmberg, S., Zibbell, J., Holtzman, D., …, & Wilson, C. (2014). Confronting the emerging epidemic of HCV infection among young injection drug users. American journal of public health, 104(5), 816–821.

50. Weinbaum, C. M., Williams, I., Mast, E. E., Wang, S. A., Finelli, L., Wasley, A., …, & Ward, J. W. (2008). Recommendations for identification and public health management of persons with chronic hepatitis b virus infection. MMWR Recomm Rep, 57(RR‐8), 1–20.
    Paper not yet in RePEc: Add citation now
    
51. Young, A. M., Havens, J. R., & Leukefeld, C. G. (2010). Route of administration for illicit prescription opioids: A comparison of rural and urban drug users. Harm Reduction Journal, 7(1), 24. https://doi.org/10.1186/1477-7517-7-24,.
    Paper not yet in RePEc: Add citation now
    

52. Zibbell, J. E., Asher, A. K., Patel, R. C., Kupronis, B., Iqbal, K., Ward, J. W., & Holtzman, D. (2018). Increases in acute hepatitis c virus infection related to a growing opioid epidemic and associated injection drug use, united states, 2004 to 2014. American journal of public health, 0, e1–e7.

1. Insurance Coverage and Provision of Opioid Treatment: Evidence from Medicare. (2023). Simon, Kosali ; Maclean, Johanna ; Cantor, Jonathan H ; Taylor, Erin ; Agniel, Denis.
   In: NBER Working Papers.
   RePEc:nbr:nberwo:31884.

   Full description at Econpapers || Download paper

2. Flipping the script: The effects of opioid prescription monitoring on specialty‐specific provider behavior. (2022). Grooms, Jevay ; Ellyson, Alice M ; Ortega, Alberto.
   In: Health Economics.
   RePEc:wly:hlthec:v:31:y:2022:i:2:p:297-341.

   Full description at Econpapers || Download paper

3. Lethal Unemployment Bonuses? Substitution and Income Effects on Substance Abuse, 2020-21. (2022). Mulligan, Casey.
   In: NBER Working Papers.
   RePEc:nbr:nberwo:29719.

   Full description at Econpapers || Download paper

4. Behavioral Responses to Supply-Side Drug Policy During the Opioid Epidemic. (2022). Liebert, Helge ; Sherry, Tisamarie B ; Balestra, Simone ; Maestas, Nicole.
   In: IZA Discussion Papers.
   RePEc:iza:izadps:dp15221.

   Full description at Econpapers || Download paper

5. Opioids and the Labor Market. (2022). Schweitzer, Mark ; Fee, Kyle ; Aliprantis, Dionissi.
   In: Working Papers.
   RePEc:fip:fedcwq:180702.

   Full description at Econpapers || Download paper

6. Behavioral Responses to Supply-Side Drug Policy During the Opioid Epidemic. (2022). Liebert, Helge ; Sherry, Tisamarie B ; Balestra, Simone ; Maestas, Nicole.
   In: CESifo Working Paper Series.
   RePEc:ces:ceswps:_9704.

   Full description at Econpapers || Download paper

7. Are prescription drug monitoring laws effective for all? Evidence from administrative data. (2022). Gupta, Sumedha ; al Achkar, Morhaf ; Ray, Bradley.
   In: Contemporary Economic Policy.
   RePEc:bla:coecpo:v:40:y:2022:i:1:p:28-47.

   Full description at Econpapers || Download paper

8. Information Avoidance and Celebrity Exposure: The Effect of Magic Johnson on AIDS Diagnoses and Mortality in the U.S.. (2021). Martin, Joshua ; Rodriguez, Zachary ; Cardazzi, Alexander.
   In: Working Papers.
   RePEc:wvu:wpaper:21-04.

   Full description at Econpapers || Download paper

9. Prescription drug monitoring programs, opioid abuse, and crime. (2021). Horn, Brady ; Deza, Monica ; Dave, Dhaval.
   In: Southern Economic Journal.
   RePEc:wly:soecon:v:87:y:2021:i:3:p:808-848.

   Full description at Econpapers || Download paper

10. The complementarity of drug monitoring programs and health IT for reducing opioid‐related mortality and morbidity. (2021). Wang, Lucy Xiaolu.
    In: Health Economics.
    RePEc:wly:hlthec:v:30:y:2021:i:9:p:2026-2046.

    Full description at Econpapers || Download paper

11. Behavioral Responses to Supply-Side Drug Policy During the Opioid Epidemic. (2021). Liebert, Helge ; Sherry, Tisamarie B ; Balestra, Simone ; Maestas, Nicole.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:29596.

    Full description at Econpapers || Download paper

12. Peltzman Revisited: Quantifying 21st Century Opportunity Costs of FDA Regulation. (2021). Mulligan, Casey.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:29574.

    Full description at Econpapers || Download paper

13. Illicit Drugs and the Decline of the Middle Class. (2021). Strulik, Holger ; Grossmann, Volker.
    In: IZA Discussion Papers.
    RePEc:iza:izadps:dp14035.

    Full description at Econpapers || Download paper

14. Labor Market Effects of the Oxycodone-Heroin Epidemic. (2021). Garcia, Daniel ; Cho, David ; Weingarden, Alison E.
    In: Finance and Economics Discussion Series.
    RePEc:fip:fedgfe:2021-25.

    Full description at Econpapers || Download paper

15. Thinking outside the box: The cross-border effect of tax cuts on R&D. (2021). Schwab, Thomas ; Todtenhaupt, Maximilian.
    In: Journal of Public Economics.
    RePEc:eee:pubeco:v:204:y:2021:i:c:s0047272721001729.

    Full description at Econpapers || Download paper

16. Is the rise in illicit opioids affecting labor supply and disability claiming rates?. (2021). Powell, David ; Park, Sujeong.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:76:y:2021:i:c:s0167629621000151.

    Full description at Econpapers || Download paper

17. Can policy affect initiation of addictive substance use? Evidence from opioid prescribing. (2021). Hollingsworth, Alex ; Nguyen, Thuy ; Simon, Kosali ; Sacks, Daniel W.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:76:y:2021:i:c:s0167629620310432.

    Full description at Econpapers || Download paper

18. Must-access prescription drug monitoring programs and the opioid overdose epidemic: The unintended consequences. (2021). Kim, Bo Kyung.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:75:y:2021:i:c:s0167629620310547.

    Full description at Econpapers || Download paper

19. Illicit drugs and the decline of the middle class. (2021). Strulik, Holger ; Grossmann, Volker.
    In: Journal of Economic Behavior & Organization.
    RePEc:eee:jeborg:v:183:y:2021:i:c:p:718-743.

    Full description at Econpapers || Download paper

20. Designing interagency responses to wicked problems: Creating a common, cross-agency understanding. (2021). Sydelko, Pamela ; Midgley, Gerald ; Espinosa, Angela.
    In: European Journal of Operational Research.
    RePEc:eee:ejores:v:294:y:2021:i:1:p:250-263.

    Full description at Econpapers || Download paper

21. Can electronic prescribing mandates reduce opioid-related overdoses?. (2021). Powell, David ; Abouk, Rahi.
    In: Economics & Human Biology.
    RePEc:eee:ehbiol:v:42:y:2021:i:c:s1570677x21000241.

    Full description at Econpapers || Download paper

22. The Intended and Unintended Effects of Opioid Policies on Prescription Opioids and Crime. (2021). Giua, Ludovica ; Ludovica, Giua ; Claudio, Deiana.
    In: The B.E. Journal of Economic Analysis & Policy.
    RePEc:bpj:bejeap:v:21:y:2021:i:2:p:751-792:n:11.

    Full description at Econpapers || Download paper

23. Breaking the Crystal Methamphetamine Economy: Illegal Drugs, Supply‐side Interventions and Crime Responses. (2021). d'Este, Rocco.
    In: Economica.
    RePEc:bla:econom:v:88:y:2021:i:349:p:208-233.

    Full description at Econpapers || Download paper

24. When Innovation Goes Wrong: Technological Regress and the Opioid Epidemic. (2021). Glaeser, Edward L ; Cutler, David M.
    In: Journal of Economic Perspectives.
    RePEc:aea:jecper:v:35:y:2021:i:4:p:171-96.

    Full description at Econpapers || Download paper

25. How well do doctors know their patients? Evidence from a mandatory access prescription drug monitoring program. (2020). Buchmueller, Thomas C ; Meille, Giacomo ; Carey, Colleen M.
    In: Health Economics.
    RePEc:wly:hlthec:v:29:y:2020:i:9:p:957-974.

    Full description at Econpapers || Download paper

26. Drugs on the Web, Crime in the Streets - The Impact of Dark Web Marketplaces on Street Crime. (2020). Zambiasi, Diego.
    In: Working Papers.
    RePEc:ucn:wpaper:202025.

    Full description at Econpapers || Download paper

27. Drugs on the Web, Crime in the Streets. The impact of Dark Web marketplaces on street crime. (2020). Zambiasi, Diego.
    In: Working Papers.
    RePEc:ucd:wpaper:202009.

    Full description at Econpapers || Download paper

28. Is the Rise in Illicit Opioids Affecting Labor Supply and Disability Claiming Rates?. (2020). Powell, David ; Park, Sujeong.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:27804.

    Full description at Econpapers || Download paper

29. Competitive Effects of Federal and State Opioid Restrictions: Evidence from the Controlled Substance Laws. (2020). Simon, Kosali ; Gupta, Sumedha ; Nguyen, Thuy D ; Freeman, Patricia R.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:27520.

    Full description at Econpapers || Download paper

30. Three Myths about Federal Regulation. (2020). Mulligan, Casey ; McLaughlin, Patrick A.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:27233.

    Full description at Econpapers || Download paper

31. Paid sick-leave and physical mobility: Evidence from the United States during a pandemic. (2020). Simon, Kosali ; Pesko, Michael ; Maclean, Johanna ; Andersen, Martin.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:27138.

    Full description at Econpapers || Download paper

32. The Evolving Consequences of OxyContin Reformulation on Drug Overdoses. (2020). Powell, David ; Pacula, Rosalie.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:26988.

    Full description at Econpapers || Download paper

33. Prices and Federal Policies in Opioid Markets. (2020). Mulligan, Casey.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:26812.

    Full description at Econpapers || Download paper

34. The Intergenerational Transmission of Opioid Dependence: Evidence from Administrative Data. (2020). Halla, Martin ; Ahammer, Alexander.
    In: Economics working papers.
    RePEc:jku:econwp:2020-10.

    Full description at Econpapers || Download paper

35. The Intergenerational Transmission of Opioid Dependence: Evidence from Administrative Data. (2020). Halla, Martin ; Ahammer, Alexander.
    In: IZA Discussion Papers.
    RePEc:iza:izadps:dp13395.

    Full description at Econpapers || Download paper

36. Retail Pharmacies and Drug Diversion during the Opioid Epidemic. (2020). Zhang, Xuan ; Janssen, Aljoscha.
    In: Working Paper Series.
    RePEc:hhs:iuiwop:1373.

    Full description at Econpapers || Download paper

37. The relationship of opioid prescriptions and the educational performance of children. (2020). Ozturk, Orgul ; Gordanier, John M ; Cotti, Chad D.
    In: Social Science & Medicine.
    RePEc:eee:socmed:v:265:y:2020:i:c:s0277953620306250.

    Full description at Econpapers || Download paper

38. Umbrella branding in pharmaceutical markets. (2020). Suppliet, Moritz.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:73:y:2020:i:c:s0167629619303856.

    Full description at Econpapers || Download paper

39. How increasing medical access to opioids contributes to the opioid epidemic: Evidence from Medicare Part D. (2020). Powell, David ; Pacula, Rosalie ; Taylor, Erin.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:71:y:2020:i:c:s0167629619303029.

    Full description at Econpapers || Download paper

40. Prices and Federal Policies in Opioid Markets. (2020). Mulligan, Casey B.
    In: Working Papers.
    RePEc:bfi:wpaper:2020-10.

    Full description at Econpapers || Download paper

41. Shackling the Identification Police?. (2019). Ruhm, Christopher.
    In: Southern Economic Journal.
    RePEc:wly:soecon:v:85:y:2019:i:4:p:1016-1026.

    Full description at Econpapers || Download paper

42. Health insurance and opioid deaths: Evidence from the Affordable Care Act young adult provision. (2019). Wettstein, Gal.
    In: Health Economics.
    RePEc:wly:hlthec:v:28:y:2019:i:5:p:666-677.

    Full description at Econpapers || Download paper

43. Adverse health effects of abuse‐deterrent opioids: Evidence from the reformulation of OxyContin. (2019). Beheshti, David.
    In: Health Economics.
    RePEc:wly:hlthec:v:28:y:2019:i:12:p:1449-1461.

    Full description at Econpapers || Download paper

44. How do Opioid Prescribing Restrictions Affect Pharmaceutical Promotion? Lessons from the Mandatory Access Prescription Drug Monitoring Programs. (2019). Simon, Kosali ; Bradford, W. David ; Nguyen, Thuy D.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:26356.

    Full description at Econpapers || Download paper

45. Can Policy Affect Initiation of Addictive Substance Use? Evidence from Opioid Prescribing. (2019). Simon, Kosali ; Hollingsworth, Alex ; Nguyen, Thuy D ; Sacks, Daniel W.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:25974.

    Full description at Econpapers || Download paper

46. A novel supply-side measure to combat abuse of addictive prescription drugs. (2019). Ahammer, Alexander.
    In: Economics working papers.
    RePEc:jku:econwp:2019_11.

    Full description at Econpapers || Download paper

47. Digital Waste? Unintended Consequences of Health Information Technology. (2019). Nurminen, Mikko ; Laine, Liisa ; Kortelainen, Mika ; Böckerman, Petri ; Bockerman, Petri ; Saxell, Tanja.
    In: IZA Discussion Papers.
    RePEc:iza:izadps:dp12275.

    Full description at Econpapers || Download paper

48. Digital Waste? Unintended Consequences of Health Information Technology. (2019). Nurminen, Mikko ; Laine, Liisa ; Kortelainen, Mika ; Böckerman, Petri ; Saxell, Tanja ; Bockerman, Petri.
    In: Working Papers.
    RePEc:fer:wpaper:117.

    Full description at Econpapers || Download paper

49. Drivers of the fatal drug epidemic. (2019). Ruhm, Christopher.
    In: Journal of Health Economics.
    RePEc:eee:jhecon:v:64:y:2019:i:c:p:25-42.

    Full description at Econpapers || Download paper

50. Shackling the Identification Police?. (2018). Ruhm, Christopher.
    In: NBER Working Papers.
    RePEc:nbr:nberwo:25320.

    Full description at Econpapers || Download paper

Report date: 2025-10-05 23:40:21 || Missing content? Let us know